Continue Inhaled Corticosteroids During Acute Diarrheal Illness
Yes, continue the inhaled corticosteroid during an acute diarrheal illness. There is no evidence-based reason to discontinue maintenance asthma therapy during a self-limited gastrointestinal illness, and stopping could precipitate loss of asthma control.
Rationale
Why Continuation is Essential
Inhaled corticosteroids are the mainstay of preventive treatment for childhood asthma, providing effectiveness with relative freedom from systemic side effects 1. The primary concern in asthma management is maintaining disease control to prevent:
- Exacerbations requiring oral corticosteroids
- Emergency department visits or hospitalizations
- Decline in lung function
- Symptom breakthrough 2
Key Clinical Considerations
Absorption and systemic effects are minimal with inhaled steroids. Unlike oral corticosteroids, inhaled formulations deliver medication directly to the airways with limited systemic absorption 1. The gastrointestinal tract is not the primary route of therapeutic action, so diarrhea does not meaningfully affect drug efficacy.
Stopping maintenance therapy creates greater risk than continuing it. Guidelines emphasize that patients should be enabled to manage treatment without requiring doctor consultation for every minor illness 1. Discontinuing inhaled corticosteroids during a viral illness (which often triggers diarrhea in children) could lead to:
- Loss of asthma control within days
- Increased airway inflammation
- Higher risk of exacerbation requiring oral steroids 2
When to Exercise Caution
Monitor for vomiting, not diarrhea. If the child is actively vomiting and cannot retain any medications or fluids, temporarily holding the inhaled steroid is reasonable until oral intake resumes. However, diarrhea alone does not impair the ability to use an inhaler.
Ensure proper inhaler technique during illness. Children should continue using their prescribed delivery device (MDI with spacer, nebulizer, or DPI) as usual 1. If the child is too ill to cooperate with inhaler use, this signals need for medical evaluation, not just medication discontinuation.
Special Populations
For children under 5 years: Continue the inhaled corticosteroid using the appropriate delivery device (nebulizer, MDI with spacer and face mask) 2. Young children with viral illnesses are at particularly high risk for asthma exacerbations 2.
For children on combination therapy: Continue both the inhaled corticosteroid and any long-acting bronchodilators as prescribed 3.
Practical Management Algorithm
- Continue inhaled corticosteroid at usual dose and frequency
- Maintain adequate hydration (the primary concern with diarrhea)
- Monitor asthma symptoms - viral illnesses often trigger asthma worsening
- Have rescue bronchodilator available for breakthrough symptoms
- Seek medical attention if:
- Asthma symptoms worsen despite continued treatment
- Child cannot tolerate any oral intake due to vomiting
- Signs of dehydration develop
- Increased work of breathing or respiratory distress occurs
The gastrointestinal illness and asthma are separate issues requiring concurrent management, not competing priorities where one treatment must be sacrificed for the other.